Caricamento...

Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma

Ramucirumab, a fully humanized monoclonal antibody directed against vascular endothelial growth factor receptor 2, is the first targeted agent to have demonstrated an improvement in survival, as a single agent or in combination, in a molecularly unselected population in gastro-oesophageal cancer. No...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Therap Adv Gastroenterol
Autori principali: Young, Kate, Smyth, Elizabeth, Chau, Ian
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2015
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622287/
https://ncbi.nlm.nih.gov/pubmed/26557893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X15592586
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !